Charles River Laboratories (CRL) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $281.27 -1.09%
Financial Fact:
Interest income: 523K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Interest income: 523K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $0.86, $0.06 better than the analyst estimate of $0.80. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $326.7 million.
Charles River Laboratories sees FY2014 EPS of $3.33-$3.38, versus prior guidance of $3.25-$3.35 and the consensus of $3.33.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
